Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 4Gastrointestinal 3Dermatologic 3Gynecologic 2Sarcoma 1Head & Neck 1

Conditions

Rectal Neoplasms 1Pathologic Processes 1Pancreatic Neoplasms 1Neoplastic Processes 1Neoplasms 1Liver Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Electrochemotherapy × Gastrointestinal × Clear all
NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed
25 enrolled 6 charts
Gastrointestinal

Liver Neoplasms

NCT03040180 2019-01-25

nECT

Zealand University Hospital

Phase 2 Unknown
40 enrolled
Gastrointestinal

Neoplasms, Neoplastic Processes, Pathologic Processes, Rectal Neoplasms, Colorectal Neoplasms

NCT03225781 2018-12-26

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Universita di Verona

Phase NA Terminated
1 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡